TwoStep Therapeutics raises $62.5m in funding to advance TS-104

Thursday, September 10, 2026Salong DebbarmaView original

TwoStep Therapeutics has raised $62.5m in Series A financing to support its lead peptide-drug conjugate, TS-104, to treat solid tumours.

Read the full article on the original site.